Phase IIa Study of S-555739 in Patients with Seasonal Allergic Rhinitis
Latest Information Update: 02 Jun 2016
Price :
$35 *
At a glance
- Drugs Asapiprant (Primary)
- Indications Seasonal allergic rhinitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Shionogi
- 02 Jun 2016 New trial record